Effects of probucol on homozygous cases of familial hypercholesterolemia
- 1 August 1983
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 48 (2) , 157-166
- https://doi.org/10.1016/0021-9150(83)90102-8
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Effect of probucol on cholesterol synthesis, plasma lipoproteins and the activities of lipoprotein and hepatic lipase in the ratAtherosclerosis, 1981
- LOWERED HDL CHOLESTEROL AND INCIDENCE OF ISCHAEMIC HEART DISEASEThe Lancet, 1981
- COMBINED EFFECTS OF PROBUCOL AND CHOLESTYRAMINE IN FAMILIAL TYPE II HYPERLIPOPROTEINAEMIAThe Lancet, 1981
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Repetitive intermittent flow plasma exchange in patients with severe hypercholesterolemiaAtherosclerosis, 1981
- Probucol in hypercholesterolemia *1A double blind studyAtherosclerosis, 1980
- ProbucolDrugs, 1978
- Two Japanese Kindreds of Familial Hypercholesterolemia Including Homozygous Cases. A Report of Cases, and Studies on Serum-Lipoproteins and EnzymesJapanese Journal of Medicine, 1978
- Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemiaAtherosclerosis, 1972
- Cholestyramine and nicotinic acid in the treatment of familial hyperbetalipoproteinaemia in the homozygous formAtherosclerosis, 1971